Skip to content

Efficacy of Ashwagandhadi Churna with Pathya-Apathyain the Management of Premenstrual Syndrome (PMS) .

Efficacy of Ashwagandhadi Churna with Pathya-Apathyain the Management of Premenstrual Syndrome (PMS) â?? An Open Labelled Randomized Placebo Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030179
Enrollment
30
Registered
2021-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases Health Condition 2: Z789- Other specified health status

Interventions

Intervention1: GROUP A-ASHWAGANDHADI CHURNA: Dose â?? 6gm(twice a day) Mode of administration: Oral Time of administration: Before meal Anupana -luke warm water Duration:From the 5th day of menstruati

Sponsors

IPGT AND RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Regular menstrual cycle, which comes in an interval of 21 to 35 days. Self-reported Premenstrual symptoms as per ACOG Criteria for more than 3 months. Self-reported impairment of occupational, family or personal functioning. Patients willing to participate in trial Hb% >7gm%

Exclusion criteria

Exclusion criteria: Females â?? Age 40 years Hb% Patients suffering from any systemic and mental illnesses. Concomitant psychotherapy Pelvic inflammatory disease Lactating mothers Patient suffering from diseases like hypertension, hypothyroidism, hyperthyroidism, uncontrolled DM. Patient with concurrent use of hormones, oral contraceptive pills, calcium and vitamin supplements.

Design outcomes

Primary

MeasureTime frame
Relief in symptoms of pre menstrual syndromeTimepoint: After the follow up period

Secondary

MeasureTime frame
improvement in life qualityTimepoint: 1 year

Countries

India

Contacts

Public ContactPROF SHILPA DONGA

IPGT AND RA GAU JAMANAGAR

drshilpadonga@yahoo.com9825646796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026